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Introduction: Postoperative morbidities, such as anastomotic leaks, 
are common after trimodality therapy (chemoradiation followed by 
surgery) for esophageal cancer. We investigated for factors associ-
ated with an increased incidence of anastomotic leaks.
Methods: Data from 285 esophageal cancer patients treated from 
2000 to 2011 with trimodality therapy were analyzed. Anastomotic 
location relative to preoperative radiation field was assessed using 
postoperative computed tomographic imaging. Logistic regression 
was used to evaluate for factors associated with any or clinically rel-
evant (CR) (≥ grade 2) leaks.
Results: Overall anastomotic leak rate was 11% (31 of 285), and CR 
leak rate was 6% (17 of 285). Multivariable analysis identified body 
mass index (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.00–
1.17; OR, 1.11, 95% CI, 1.01–1.22), three-field surgery (OR, 10.01; 
95% CI, 3.83–26.21; OR, 4.83; 95% CI, 1.39–16.71), and within radi-
ation field (“in-field”) anastomosis (OR, 5.37; 95% CI, 2.21–13.04; 
OR, 8.63; 95% CI, 2.90–25.65) as independent predictors of both all 
grade and CR leaks, respectively. While patients with distal esophageal 
tumors and Ivor-Lewis surgery had the lowest incidence of all grade 
(6.5%) and CR leaks (4.2%), most of the leaks were associated with 
the anastomosis constructed within the field of radiation (in-field: 39% 
and 30% versus out-of-field: 2.6% and 1.0%, respectively, for total and 
CR leaks, p less than 0.0001, Fisher’s exact test).
Conclusions: Esophagogastric anastomosis placed within the pre-
operative radiation field was a very strong predictor for anastomotic 
leaks in esophageal cancer patients treated with trimodality therapy, 
among other factors. Surgical planning should include a critical eval-
uation of the preoperative radiation fields to ensure proper anasto-
motic placement after chemoradiation therapy.
Key Words: Anastomotic leaks, Esophagectomy, Radiation, 
Esophageal cancer, Trimodality therapy.
(J Thorac Oncol. 2014;9: 534–540)
Surgical resection alone remains a worldwide standard for the management of esophageal cancer, but the 5-year sur-
vival usually does not exceed 20%.1 Neoadjuvant chemora-
diation before surgical resection (trimodality therapy) allows 
for disease downstaging and increases tumor resectability, 
with increased cure rates. Older randomized trials demon-
strated probable survival benefit of preoperative chemo-
radiation although a number of negative studies made the 
indication controversial. A meta-analysis of the trials showed 
a 2-year overall survival benefit of 13% for patients treated 
with neoadjuvant chemoradiation followed by surgery com-
pared with patients treated with surgery alone.2 Recently, a 
large randomized trial demonstrated significant improvement 
in overall survival and disease-free survival with the use of 
neoadjuvant chemoradiation compared with surgery alone.3 
Chemoradiation before surgery improved median overall sur-
vival to 49.4 months compared with 24.0 months in patients 
treated with surgery alone.
However, preoperative chemoradiation increases the 
chance for toxicity and postoperative morbidity compared with 
surgery alone. There are several nonrandomized studies in the lit-
erature that showed an increase in surgical morbidity in patients 
undergoing neoadjuvant chemoradiation.4–7 Postoperative pul-
monary complications have been well studied and have been 
shown to be related to radiation dose to the lungs.8
The effects of neoadjuvant radiation on postoperative 
anastomotic leaks have been less extensively studied. In an 
older study, anastomotic leaks were found in 17% of patients 
who underwent esophagectomy with cervical anastomosis; 
however, the use of preoperative radiotherapy was not associ-
ated with the incidence of leaks.9 A systematic review showed 
that reports in the literature for anastomotic leak rates vary 
between 0% and 26% and that the leak rate is not influenced 
by method of anastomosis, either stapled or hand-sewn.10 A 
recent Belgian study with 54 patients treated with neoadjuvant 
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radiation followed by Ivor-Lewis esophagectomy showed that 
the dose to the gastric fundus was a significant predictor for 
anastomotic complications (leakage, ischemia, and stenosis).11
The aim of the present study was to determine the clini-
cal and dosimetric factors that can influence the risk of devel-
oping any grade leaks or the more clinically relevant leaks of 
≥ grade 2 (or what we will term as “CR leaks” throughout the 
article) in patients undergoing trimodality therapy. Dose to the 
whole stomach and associated gastric substructures were stud-
ied as well as the impact of the positioning of radiation field 
and the location of the anastomotic site.
PATIENTS AND METHODS
Patient Data
This investigation was approved by the institutional 
review board and was conducted in compliance with the 
Health Insurance Portability and Accountability Act. This 
was a retrospective analysis of esophageal cancer patients 
treated at M. D. Anderson Cancer Center with neoadjuvant 
chemoradiation followed by surgery between 2000 and 
2011. Because we wanted to evaluate the radiation dosim-
etry to the stomach, only patients with full dose-volume his-
togram data were included. Patients who had gastrectomy 
were excluded. We also included only patients treated with 
photon-based therapy (three-dimensional conformal radia-
tion therapy [3D-CRT] or intensity-modulated radiation 
therapy [IMRT]).
A thorough chart review was done to document the clin-
ical and treatment-related factors for this cohort of patients. 
Following surgery, follow-up monitoring included interval 
history and physical examination at the discretion of the treat-
ing physicians. Incidence of perioperative anastomotic leaks 
was recorded by grade for each patient, defined as radio-
graphic leak only (grade 1), minimal intervention/stent place-
ment (grade 2), major intervention/reoperation (grade 3), 
and conduit loss (grade 4). CR leaks were defined as leaks ≥ 
grade 2. Postsurgical computed tomography (CT) scans were 
examined to determine if surgical anastomosis was in or out of 
the radiation field. Contouring of the whole stomach, fundus, 
antrum, and lateral body was done by one person using the 
Pinnacle planning software. Associated 3D and IMRT treat-
ment plans were used to generate dose-volume histograms for 
each of the contoured gastric regions of interest.
Treatment Approach
Patients in this study cohort were treated with neo-
adjuvant chemoradiation of 50.4 Gy at 1.8 Gy per frac-
tion. Combinations of 5-fluorouracil and taxane, or with 
 platinum-based compounds were administered concurrently 
with radiotherapy. Several weeks after completion of chemo-
radiation, most patients were restaged using CT, positron 
emission tomography/CT, or esophagoduodenoscopy (EGD) 
with biopsy of the primary disease site and evaluated for sur-
gical management. The most common esophagectomy pro-
cedure was Ivor-Lewis, whereas a few patients also received 
transhiatal, left thoracotomy, radical (en block) resection, or 
minimally invasive esophagectomy.
The technique of 3D-CRT or IMRT was used for this patient 
cohort. The internal gross tumor volume was delineated based on 
the four-dimensional CT simulation images to account for tumor 
motion relative to diaphragmatic motion, fluorodeoxyglucose 
(FDG)-positron emission tomography/CT, and endoscopy results. 
The clinical target volume (CTV) included the internal gross 
tumor volume with a radial margin of 0.5 to 1 cm and a proxi-
mal and distal margin of 3 to 4 cm. Elective nodal regions were 
not covered, unless in the proximal locations where the supracla-
vicular fossa bilaterally were included in the target volume, and 
in the distal esophagus where the celiac axis was covered if it was 
involved. The nodal CTV was defined by 0.5 to 1 cm expansion 
from the nodal gross tumor volume. The planning target volume 
was the CTV plus a uniform 0.5-cm expansion margin.
Statistical Methods
Logistic modeling was used to assess associations 
between leak incidence and various continuous and categori-
cal variables. The continuous variables studied were age, 
body mass index (BMI), tumor length, planning target vol-
ume, prescribed dose, and mean dose to whole stomach, lat-
eral body, antrum, and fundus. Categorical variables studied 
were Karnofsky Performance Status, coronary artery disease 
history, diabetes history, smoking history, tumor location, 
presence of in-field anastomosis, radiation modality, use of 
induction chemotherapy, salvage surgery (defined as ≥90 days 
after chemoradiation), surgical margin status (R0 versus R1–2), 
and type of surgery (Ivor-Lewis, transhiatal, three-field, or 
hybrid). Logistic regression analysis was then used to per-
form multivariable analysis of factors that were significant 
(p ≤ 0.05) on univariable analysis. The two-tailed Fisher’s 
exact test was used to test the significance of proportions.
RESULTS
Patient Cohort
A total of 285 patients diagnosed with esophageal can-
cer and treated with neoadjuvant chemoradiation followed by 
esophagectomy were included in our analysis; 158 patients 
were treated with 3D-CRT and 127 were treated with IMRT. 
Concurrent chemotherapy was given to all patients during 
chemoradiation, and 151 patients were treated with induction 
chemotherapy before chemoradiation. Following radiation, 
the most common surgical procedure was Ivor-Lewis sur-
gery (n = 222) followed by three-field and transhiatal surgery 
(n = 31 and 29, respectively). Three patients had hybrid open 
thoracotomy/laparoscopy resections. Nearly all of the patients 
had creation of a gastric conduit (97.9%, 279 of 285) with 
only five cases of jejunal interposition (for one case the ori-
gin of the conduit is not known). There was no association 
between leaks and jejunal interposition (3 of 5 had no leaks).
Factors Associated with Anastomotic Leaks
Overall, there were 14 grade 1, 8 grade 2, 8 grade 3, and 
1 grade 4 leaks. Anastomotic leaks of any grade occurred in 31 
patients for an overall incidence rate of 11%, and 17 patients 
(6%) had grade 2 or higher leaks. Table 1 shows patient and 
treatment-related characteristics that were associated with the 
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occurrence of any or CR anastomotic leak based on univariable 
analysis. For any grade leaks, tumor location, in-field anastomo-
sis, and type of surgery (three-field versus others) were factors 
associated with anastomotic leaks. In addition, lower mean doses 
to stomach and substructures were associated with increased 
incidence of anastomotic leaks. For CR leaks, BMI, diabetes, 
tumor location, in-field anastomosis, and the type of surgery 
were significant factors associated with the occurrence of leaks.
Multivariable Analysis
Stepwise forward and backward multivariable analyses 
were performed using candidate factors that were significant 
at p less than 0.05 on univariable analysis. Subsequently, fac-
tors that were not included as candidate factors in the initial 
multivariable analysis because of the lack of univariable sig-
nificance were tested for their ability to improve the model fit. 
For both all grade and CR leaks, the factors selected as inde-
pendent predictors were BMI, three-field surgery, and in-field 
anastomosis (Table 2).
Incidence of Leaks Associated 
with the Predictive Factors
Patients with anastomosis done inside the radiation field 
had a significantly higher incidence of leaks of all grades when 
compared with anastomoses that were placed outside the radia-
tion field (31.8% versus 7%, p < 0.0001). Findings were similar 
for high-grade leaks as well (15.9% versus 3.7%, p < 0.0001). 
We evaluated the incidence of CR anastomotic leaks in relation 
to the significant factors that were discovered in the multivari-
able analysis. For BMI, we analyzed the incidence of CR leaks 
using the median BMI (28 kg/m2) as a cutoff. The incidence of 
any grade leaks only trended for but was not significantly lower 
in patients with a BMI less than 28 kg/m2 (12 of 143, 8.4%) 
than in patients with BMI greater than or equal to 28 kg/m2 
(19 of 142, 13.4%, p = 0.189). However, the incidence of CR 
leaks was statistically significantly lower in patients with a BMI 
less than 28 kg/m2 (4 of 143, 2.8%) than in patients with BMI 
greater than or equal to 28 kg/m2 (13 of 142, 9.2%, p = 0.025).
While upper/middle tumor location was a significant 
risk factor for the development of anastomotic leak on uni-
variable analysis, this factor was no longer significant on 
multivariable analysis. The reason is that tumor location was 
strongly associated with the probability of in-field anasto-
mosis: 14 of 21 patients with upper/middle tumors had in-
field anastomosis (67%) compared with 30 of 263 patients 
with lower tumors (11%) (p < 0.001). To take this further, 
we evaluated the incidence of CR leaks based on tumor 
location and anastomotic location relative to the radiation 
field (Table 3). The large majority (92%) of patients in our 
TABLE 1.  Univariable Analysis of Factors Associated with Anastomotic Leaks
Continuous Variables Median Range
All Grades Grade ≥ 2
OR p OR p
Age (yr) 61 29–79 0.99 0.590 1.01 0.818
BMI (kg/m2) 28 5.3–50.3 1.05 0.136 1.10 0.031
Tumor length (cm) 5 0–15 0.95 0.537 0.98 0.888
PTV (cm3) 759 127–2609 1.00 0.733 1.00 0.547
Mean dose stomach (Gy) 39.1 0.04–60.4 0.97 0.035 0.99 0.478
Mean dose lateral body (Gy) 44.4 0.05–68.6 0.98 0.028 0.98 0.166
Mean dose fundus (Gy) 48.3 0.06–70.0 0.97 0.025 0.98 0.245
Mean dose antrum (Gy) 21.9 0.02–55.2 0.98 0.176 1.01 0.668
Categorical Variables Reference (N) Comparator (N)
All Grades Grade ≥ 2
OR p OR p
KPS 70–80 (133) 90–100 (145) 1.24 0.576 0.59 0.305
Diabetes Yes (42) No (243) 2.25 0.071 3.52 0.020
Alcohol use Yes (61) No (223) 1.31 0.535 2.10 0.161
Coronary artery disease Yes (24) No (260) 1.73 0.350 1.48 0.615
Smoking historya Yes (198) No (85) 0.76 0.484 1.42 0.548
Tumor location Upper-mid (21) Lower (163) 4.98 0.002 4.52 0.016
In-field anastomosis Yes (44) No (241) 6.15 <0.001 9.83 <0.001
Induction chemotherapy Yes (151) No (134) 0.81 0.588 0.77 0.615
Radiation modality IMRT (127) 3D (158) 0.89 0.755 1.11 0.831
Type of surgery Three-field (31) Others (254) 9.47 <0.001 5.30 0.002
Salvage surgery Yes (40) No (245) 0.90 0.848 0.81 0.781
Margin status R1–2 (39) R0 (246) 2.02 0.133 1.14 0.625
aN = 35 were unknown and excluded.
BMI, body mass index; IMRT, intensity-modulated radiation therapy; KPS, Karnofsky Performance Status; OR, odds ratio; PTV, planning tumor volume.
Bold indicates p values < 0.05
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cohort had tumors located in the lower third of the esopha-
gus. When compared with patients with lower esophageal 
cancers, the overall leak rate was significantly higher for 
patients with upper esophageal tumors (33% versus 9%, 
p = 0.004). This was also true for CR leaks (19% versus 5%, 
p = 0.028). However, leaks rates were nearly equal regard-
less of tumor location if the anastomosis was in-field. For all 
grades of leaks, patients with both in-field anastomosis and 
an upper or middle esophagus tumor location had an anas-
tomotic leak rate at 36% (5 of 14), which was not different 
from the patients with distal tumors and in-field anastomosis 
(9 of 30, 30%, p = 1.00). This was also true for CR leaks 
(21% versus 23% for upper/middle versus distal location, 
respectively). For patients with out-of-field anastomosis, 
the leak rate seems to differ based on tumor location, with 
higher leak rates for upper/middle location compared with 
distal locations, but these were not statistically significant 
(Figure 1). On the contrary, patients with distal esophageal 
tumors and an out-of-field anastomosis had a total leak rate 
of 6.4%, which was statistically significant compared with 
in-field anastomosis of 30% (p = 0.0004) (Figure 2). For CR 
leaks, distal locations had only a 2.5% risk if the anastomo-
sis was out of field, which was significantly lower than the 
risk of in-field anastomosis (23%, p = 0.0001). To remove 
the potential confounding factor of the different surgery 
techniques used for tumors in the distal location, we con-
fined our analysis to only the patients who had Ivor-Lewis 
esophagectomies (n = 215). The overall leak rate was 6.5% 
and the CR leak rate was 4.2%. We found that the rate of all 
grade and CR leaks were 39% (9 of 23) and 30% (7 of 23), 
respectively, when the anastomosis was placed in-field ver-
sus 2.6% (5 of 192) and 1.0% (2 of 192), respectively, if the 
anastomosis was placed out-of-field. The differences were 
highly significant (p < 0.0001).
The differences in incidence of all grade and CR leaks 
were also significantly influenced by the type of surgery. The 
observed incidence rates for all grades and CR leaks were 16 
of 222 (7.2%) and 10 of 222 (4.5%) for Ivor-Lewis, 13 of 31 
(41.9%) and 6 of 31 (19.4%) for three-field surgery, 2 of 29 
(7%) and 1 of 29 (3.4%) for transhiatal surgery, and 0 of 3 and 
0 of 3 for patients who had hybrid surgery, respectively. To 
determine if three-field surgery was associated with an even 
higher rate of complications, we examined grade 3 and higher 
leaks and association with the type of surgery. Only 2 of 31 
(6.4%) with three-field surgery had grade 3–4 leaks when 
compared with 7 of 254 (2.8%) who received other types of 
surgery, the difference of which was not statistically signifi-
cant (odds ratio, 2.43; p = 0.281).
TABLE 2.  Multivariable Analysis of Significant Predictors of Anastomotic Leaks
Variables
All Grades Grade ≥ 2
OR 95% CI p OR 95% CI p
BMI 1.09 1.00–1.17 0.032 1.11 1.01–1.22 0.021
Three-field surgery 10.01 3.83–26.21 0.000 4.83 1.39–16.71 0.013
In-field anastomosis 5.37 2.21–13.04 0.000 8.63 2.90–25.65 0.000
BMI, body mass index; CI, confidence interval; OR, odds ratio.
TABLE 3.  Anastomotic Leaks in Relation to Anastomosis Location
Tumor Location (N) Total Leaks (%)
In-Field (N = 14) Out-of-Field (N = 7)
pN % N %
Upper/middle (21) 7 (33) 5 35.7 2 28.6 1.000
Tumor Location (N) Total Leaks (%)
In-Field (N = 30) Out-of-Field (N = 233)
pN % N %
Distal (263) 24 (9) 9 30 15 6.4 0.0004
p = 0.0036 p = 0.7384 p = 0.0804
Tumor Location (N) Grade ≥ 2 Leaks (%)
In-Field (N = 14) Out-of-Field (N = 7)
pN % N %
Upper/middle (21) 4 (19) 3 21 1 14 1.000
Tumor Location (N) Grade ≥ 2 Leaks (%)
In-Field (N = 30) Out-of-Field (N = 233) p
N % N %
Distal (263) 13 (5) 7 23 6 2.5 0.0001
p = 0.0280 p = 1.000 p = 0.1893
p value significance comparing groups vertically or horizontally.
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DISCUSSION
Our findings in this study demonstrated that the anasto-
motic location relative to the field of radiation is an important 
factor influencing the occurrence of postoperative leaks after 
esophagectomy. Although there are reports to suggest that neo-
adjuvant therapy, either chemotherapy or radiation, does not 
substantially increase the postoperative morbidity for patients 
who undergo esophagectomies,12 there is substantial evidence 
in the literature to suggest that neoadjuvant chemoradiation 
increases the rate of postoperative morbidity and mortality. 
A meta-analysis of randomized trials of patients with resect-
able esophageal cancer showed that chemoradiation was a risk 
factor for postoperative mortality (odds ratio, 1.18–3.73; p = 
0.01).13 A Japanese retrospective analysis of 686 esophageal 
cancer patients also showed that neoadjuvant chemoradiation 
was an independent predictor for postoperative complications 
with an anastomotic leak rate of 28% in patients who received 
neoadjuvant radiation compared with 16.5% in patients who 
had surgery alone (p < 0.05).14 Our observed total leak rate 
of 11% was comparatively lower, but this could be due, in 
part, to the surgical approaches used in the different studies, 
since in the published studies the rates were only about 7% 
for both transhiatal and Ivor-Lewis patients, which is about 
what we see for our patient cohort who received Ivor-Lewis 
esophagectomy (6.5%). We found that three-field esophagec-
tomy was a significant risk factor for anastomotic leak on mul-
tivariable analysis with a leak rate of 42%.
Vande Walle et al.11 reported a 5.6% anastomotic leak 
rate in their study showing the significance of D
50
 to the gas-
tric fundus (the total dose delivered to 50% of the volume) as a 
risk factor for anastomotic complications. To our knowledge, 
this was the only published evidence that showed radiation 
dose to the stomach as a risk factor for anastomotic complica-
tions. Although we did find an association of the mean dose 
to the stomach and substructures to the incidence of all grade 
leaks, the higher mean dose was associated with a protective 
effect rather than a detrimental effect. We believe that this par-
adoxical effect was attributed to the mean dose being inversely 
related to both the incidence of in-field anastomosis and 
 three-field surgery (Supplementary Figure 2, Supplemental 
Digital Content, http://links.lww.com/JTO/A536). Patients 
with upper and middle esophagus tumors were significantly 
more likely to have anastomotic leaks because more in-field 
anastomosis occurs in this location and, consequently, have 
lower dose to the gastric structures. Three-field surgery was 
also more likely to be in upper-esophageal locations (12 of 
21, 57%) compared with the lower esophageal location (19 
of 263, 7.2%) (p < 0.0001). Although patients with lower 
FIGURE 1.  Illustration of a case with out-of-field anastomosis. A, Simulation CT imaging of a midesophageal tumor with treat-
ment plan encompassing areas below the aortic arch. B, Post-Ivor-Lewis esophagectomy CT imaging showing postoperative 
anatomy. White arrows point to the area of anastomosis above the aortic arch. This patient did not develop anastomotic leak. 
CT, computed tomography.
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esophageal tumors were associated with increased dose to the 
stomach, this did not increase the rate of anastomotic break-
down. Surgeons at our institution often take special care to 
exclude the irradiated stomach when creating the esophago-
gastric anastomosis.
There have been other factors that are associated with 
anastomotic leaks regardless of the use of neoadjuvant chemo-
radiation. An earlier study from India found that low albu-
min, tumor involvement of the anastomotic cut margin, and 
cervical anastomosis were predisposing factors for leaks in 
patients who had upfront surgery.15 A second study, also in pri-
mary resected patients for both benign and malignant disease, 
found active smoking history, postoperative arrhythmias, and 
manually sewn versus side-to-side stapled anastomosis as risk 
factors for leaks.16 Although we were able to identify some 
patient factors, such as diabetes and higher BMI, as risk fac-
tors for anastomotic leaks, most of what we identified as criti-
cal risk factors were related to the tumor location, the type of 
surgery, and where the anastomosis was placed. We believe 
that the different findings between our study and the afore-
mentioned ones were primarily due to the use of chemora-
diation in all the patients included in our study, which likely 
overshadowed other potential risk factors. A major finding 
of our study was that esophagogastric anastomosis placed 
in the previously irradiated field was significantly associated 
with increased leak rate. For these cases, irradiated normal 
tissues in proximity to the normal esophagus were included 
in the proximal portion of the esophagogastric anastomosis. 
Patients with upper or middle esophageal tumor location have 
their radiation treatment portals at or near the sites of thoracic 
or cervical anastomosis and therefore are more likely to have 
high doses of radiation targeted to normal tissue in this region. 
Upper/middle tumor location was a significant predictor of 
anastomotic leak on univariable analysis but was not included 
in the multivariable model, when the anastomotic site rela-
tive to the radiation field was taken into account. The leaks in 
the distal location were nearly fully accounted for by whether 
the anastomosis was placed in-field or out-of-field. However, 
the incidence of leaks in the upper/middle esophageal loca-
tion was high regardless of whether the anastomosis was done 
in-field or out-of-field. Perhaps the number of cases was too 
small in this location to determine a statistically significant 
relationship with the field of anastomosis, but there could be 
other anatomic or clinical factors that were not accounted for 
that place the upper/middle tumor location at higher risk of 
developing leaks, independent of the type of surgery or the 
field of anastomosis.
To our knowledge, there was only one previous study 
that had evaluated the relationship of radiation field with anas-
tomotic leak rates. This was in a cohort of 38 patients treated 
with radiation and esophagogastrectomy. They found that 
there was no increased leaks observed when the anastomosis 
FIGURE 2.  Illustration of a case with in-field anastomosis. A, Simulation CT imaging of a midesophageal tumor with treatment 
plan encompassing areas below the aortic arch. B, Post-Ivor-Lewis esophagectomy CT imaging showing postoperative anatomy. 
White arrows point to the area of anastomosis at the level of carina within the radiation treatment field. This patient developed 
grade 3 anastomotic leak. CT, computed tomography.
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was located in the preoperative radiation field.17 The reason 
for the discrepancy between their study and ours is unclear, 
but it is likely that the number of patients in their study was 
too small to make a significant association. It is well estab-
lished that radiation leads to damage to the microvasculature 
and the resulting ischemia can slow tissue healing in irradi-
ated fields.18–20 Patients with diabetes often have issues with 
microvasculature and wound healing as well. Our analysis also 
showed a higher leak rate for patients with diabetes, though it 
was not statistically significant on multivariable analysis (19% 
versus 9.5%, p = 0.101, Table 1).
Our study is limited by the retrospective nature of the 
analysis, which cannot account for all potential factors that 
could explain some of our findings. While the surgical pro-
cedures at our institution have been standardized to a certain 
extent, multiple surgeons were involved over the time span 
of the study so some variation inevitably exists. Furthermore, 
anatomic configuration and blood supply to both the stom-
ach and the esophagus are varied across the patient popula-
tion, posing a potential confounding factor that could not be 
accounted for in a retrospective analysis.
In conclusion, the present study demonstrates that the 
placement of the esophagogastric anastomosis within the pre-
operative radiation field is a strong, independent predictor for 
anastomotic leaks in esophageal cancer patients treated with 
trimodality therapy. These results have important implications 
in careful preoperative planning to minimize postoperative 
leak complications.
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